This story originally ran on May 13.

Aiming to gain a clearer understanding of the effects of drug abuse on the progression of HIV/AIDS, the US National Institute of Drug Abuse awarded researchers at Case Western Reserve University a three-year, $3 million grant to develop protein and epigenetic biomarkers and new technology to track progression of the disease, the school announced last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.